Chemical Name: 1,1-Bis(di-tert-butylphosphino)ferrocene
CAS.NO:84680-95-5
Molecular Formula:C26H44FeP2
Molecular Weight:474.42000
Synonyms:
1,1'-BIS(DI-TERT-BUTYLPHOSPHINO)FERROCENE
Physical and Chemical Properties:
Density: /
Boiling point:/
Melting point: 181-182°C
Flash point: /
Refractive index: /
Specification:
Appearance:Yellow Powder
Purity:≥98%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:used as a catalyst for the asymmetric hydroformylation of styrene and vinyl acetate.
We are professional 1,1-Bis(di-tert-butylphosphino)ferrocene manufacturer and 1,1′-BIS(DI-TERT-BUTYLPHOSPHINO)FERROCENE supplier in China, We offer quality 1,1-Bis(di-tert-butylphosphino)ferrocene you can fully trust, also we have India factory and producer of 1,1′-BIS(DI-TERT-BUTYLPHOSPHINO)FERROCENE,Pls send inquiry of 1,1′-BIS(DI-TERT-BUTYLPHOSPHINO)FERROCENE CAS:84680-95-5 to info@nbinno.com if you have any interests, thank you!
Related News: Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.4,4-Dimethyl-3,5,8-trioxabicyclo[5.1.0]octane CAS:57280-22-5 As one of the world’s largest API producers and exporters, China’s chemical API production and operating income show steady growth.2,6-di (propan-2-il) anilina CAS:24544-04-5 As one of the world’s largest API producers and exporters, China’s chemical API production and operating income show steady growth.104116-17-8 Chung also said South Korean citizens who had visited the province in the past 14 days should voluntarily quarantine themselves at home for two weeks after they arrive back into the country.Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.
